Clinical Trial Update: Pharmacogenetics of Response to GLP1R Agonists [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial updating on pharmacogenetic factors that may influence how patients respond to GLP-1 receptor agonists for obesity and Type 2 diabetes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonists (class)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Obesity, Diabetes Type 2 | Phase 1 | Status: RECRUITING